- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT05142813
A Blood Test to Diagnose Sepsis in Symptomatic Adults and Children
A Cohort Study to Evaluate Biomarkers as Indicator for the Infectious Source of Sepsis Through a Blood Test
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
The purpose of this prospective, non-interventional study is to develop and validate a blood gene expression test for diagnosing the cause of sepsis in adults and children with symptoms of infection.
Sepsis affects 31.5 million people globally leading to 5.3 million deaths each year. Sepsis is particularly harmful to immunodeficient patients undergoing cancer therapy with 3.7 percent to 6.4 percent of cancer patients diagnosed with sepsis in the US in their first year after cancer diagnosis. Current tests to diagnose the infectious cause of sepsis rely on blood cultures which takes 24-48 hours to complete; leading to delays in early treatment critical to reduce the risk of developing sepsis shock and possibly death. In addition, around 50 percent of severe sepsis cases are culture negative, confounded acute infections not detected in the blood, by viral infection or uninfected patients exhibiting systemic inflammatory response syndrome (SIRS). Since sepsis often progresses to sepsis shock within 72 hours, suspected sepsis cases are usually immediately treated with antibiotics until results from testing distinguish the cause of symptoms. This leads to the over-use of antibiotics and delays appropriate treatment for those without bacterial infection or un-infected SIRS.
A quick and accurate diagnostic blood test may enable early discrimination of the cause of sepsis resulting in faster more appropriate treatments and reduced sepsis complications and death.
The study will collect blood samples from participants presenting symptoms of acute infection, without co-morbidities and follow symptom severity and mortality for 28 days.
Studietyp
Inskrivning (Förväntat)
Kontakter och platser
Studiekontakt
- Namn: James Schilling
- Telefonnummer: 650479198
- E-post: admin@mprobe.com
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Criteria: Inclusion Criteria:
- Clinical suspicion of an acute infectious disease
Presence of at least ONE of the following:
- Temperature ≥ 38°C or Temperature ≤ 36°C
- Heart rate > 90 bpm
- Respiratory rate > 20/min
- Self reported fever/chills
- Symptom duration ≤ 7 days
Exclusion Criteria:
- Received antibiotics or antivirals in the past 2 weeks.
- Previous infection in previous 2 weeks
- Primary or secondary immunodeficiency
- Proven or suspected HIV, hepatitis B or hepatitis C infection
- Current immune-suppressive or immune-modulating treatment
- Active hematological malignancy
- Other illnesses that affect life expectancy
Studieplan
Hur är studien utformad?
Designdetaljer
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Diagnosis of underlying cause of sepsis infection
Tidsram: 1 month
|
The sensitivity and specificity of the assay in differentiating bacterial from viral infection.
|
1 month
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Diagnosis of underlying cause of acute infection symptoms
Tidsram: 1 month
|
The sensitivity and specificity of the assay in differentiating infectious and non-infectious disease.
|
1 month
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Jia Huang, The Second Afliated Hospital of Southern University of Science and Technology
Studieavstämningsdatum
Studera stora datum
Studiestart (Förväntat)
Primärt slutförande (Förväntat)
Avslutad studie (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- Sepsis_001
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Infektioner
-
Institut PasteurRekrytering
-
Duke UniversityAvslutadCentral Line-associated Bloodstream Infection (CLABSI)Förenta staterna
-
Catholic University of the Sacred HeartAvslutadCentral Line-associated Bloodstream Infection (CLABSI)
-
The University of Texas Health Science Center,...EurofinsAvslutadOdontogen Deep Space Neck InfectionFörenta staterna
-
Princess Maxima Center for Pediatric OncologyUMC Utrecht; Dutch Cancer SocietyRekryteringCentral Line-associated Bloodstream Infection (CLABSI)Nederländerna
-
University of MalayaTeleflexRekryteringCLABSI - Central Line Associated Bloodstream InfectionMalaysia
-
Johns Hopkins UniversityAvslutadCLABSI - Central Line Associated Bloodstream InfectionFörenta staterna
-
National Taiwan University Hospital Hsin-Chu BranchAvslutadCentral Line-associated Bloodstream Infection (CLABSI)
-
National Taiwan University HospitalAvslutadCentral Line-associated Bloodstream Infection (CLABSI)Taiwan
-
Boston Children's HospitalSterileCare Inc.Anmälan via inbjudanCentral Line komplikation | Central Line-associated Bloodstream Infection (CLABSI)Förenta staterna
Kliniska prövningar på Diagnostic Test: Blood specimen collection
-
Foundation for Innovative New Diagnostics, SwitzerlandKenya Medical Research InstituteHar inte rekryterat ännuVisceral leishmaniasis
-
IdentigeneCRI Lifetree Clinical ResearchOkänd
-
PATHHar inte rekryterat ännuPrimära immunbristsjukdomarPakistan
-
Sequenom, Inc.Labcorp Corporation of America Holdings, IncRekryteringInfluensa A | RSV-infektion | COVID-19 luftvägsinfektion | Influensa typ BFörenta staterna
-
Abbott Rapid DxBill and Melinda Gates FoundationAvslutad
-
London School of Hygiene and Tropical MedicineHealthNet TPO; Health Protection and Research Organisation; Medical Emergency...AvslutadLunginflammation | Feber | Malaria | Akut febersjukdomAfghanistan
-
PATHCentro de Pesquisa em Medicina Tropical de RondoniaRekrytering
-
University of OxfordAvslutadPlasmodium Falciparum MalariaThailand
-
University of Alabama at BirminghamNational Heart, Lung, and Blood Institute (NHLBI)Rekrytering
-
Institut de Recherche en Sciences de la Sante,...RekryteringAntimikrobiell resistensBurkina Faso